Head of Community Programmes and Education

Katie holds a Bachelor of Arts in Journalism and Mass Communication from the University of North Carolina at Chapel Hill and a Master of Arts from Georgetown University in Liberal Studies with a concentration in International Affairs. Katie has a decade of experience with nonprofit organizations and higher education institutions. Prior to joining MPE, Katie served as the Director of Development at a large New York City nonprofit supporting individuals with developmental disabilities where she…

Natasa Hace

Policy and Public Affairs manager

She holds a degree in law specialized in EU and International Law and has broad experience being involved in several key cancer initiatives at a national and a European level. Nataša worked in Brussels for public affairs consultancy mostly in the field of health, environment and consumer protection, before assisting MEP setting up the informal group against cancer in the European Parliament, moving on to advocacy and representing the views of cancer patients for the…

Access to medicines Secretariat

Anne-Pierre brings 20 years of experience with a wide range of healthcare stakeholders (charity, patient organisation, governmental agency, consultancy and pharmaceutical industry). Her skills and expertise in health communication, cancer prevention and market access, combined with her personal experience as a leukaemia survivor, give her a unique perspective on patient engagement, advocacy and equal access to adequate care. Anne-Pierre holds a MSc in Economic Evaluation for Health Technology Assessment from the University of York, a…

Kate Morgan

Head of Policy and Access

She holds a Bachelor’s degree in Government from the London School of Economics and Political Sciences and a Master’s degree in International and European Politics from the University of Edinburgh. She also holds a Diploma in Public Relations from the Chartered Institute for Public Relations. Her main area of interest is health policy, with a specific focus on policies affecting drug development and access in European countries. Kate previously worked for eight years in the…

Chief Executive Officer (CEO)

Chief Executive Officer

Nikita has been a board member of MPE since March 2020.

Nikita is cofounder of the Society for Assistance to Patients with Oncohaematological Diseases in Russia. He is a haematologist and psychotherapist. He participated in the foundation of the first organisation of haematological patients in the Russian Federation, the Charity Foundation “Haematology and Intensive Care” and he is founder of an Independent Association for Inpatient Psychological Care.

Lise-lott is the board member of MPE since March 2019.

Lise-lott has been Chairman of the Swedish Blood Cancer Association since 2015 and was previously Chairman of the Blood Cancer Society in Stockholm. Lise-Lott lives in Stockholm, Sweden. She was diagnosed with essential thrombocytemia in 2011 and her father was diagnosed with myeloma in 2009. In the Swedish Blood Cancer Association, she is very active in policy related issues within the Swedish cancer care area with focus on access to new drugs for hematological disorders…

Roman is a board member since April 2018.

Roman is member of the Polish organisation Carita Zyc Ze Szpiczakiem and a smouldering myeloma patient since 2012. He completed higher law studies in Lodz, Poland, LL.M studies (EU Comparative Law) at Rijksuniversiteit Limburg in Maastricht, the Netherlands. He worked a long-time as lawyer at EY and he is currently working mainly with corporate clients such as General Electric, Emerson Electric and Ford.

Kristina is a board member of MPE since October 2016.

Biljana is the president and project manager of “BORKA – for each new day”, MPE’s Macedonian member. Biba, as she is known, is a Macedonian singer-songwriter, musician and producer. After her mother’s melanoma diagnosis, she decided to use her celebrity status to create the Association “BORKA – for each new day” and be the voice of patients by generating awareness about cancer and problems in the health industry and to work for patients’ rights in…